Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
12312 | 851 | 29.1 | 61% |
Classes in level above (level 2) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
485 | 14922 | TRANSFUSION//VOX SANGUINIS//BLOOD TRANSFUSION |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | PLATELET TRANSFUSIONS | Author keyword | 28 | 27% | 10% | 87 |
2 | PLATELET REFRACTORINESS | Author keyword | 20 | 67% | 2% | 18 |
3 | HLA ALLOIMMUNIZATION | Author keyword | 9 | 83% | 1% | 5 |
4 | PLATELET TRANSFUSION REFRACTORINESS | Author keyword | 7 | 56% | 1% | 9 |
5 | PLATELET DOSE | Author keyword | 6 | 80% | 0% | 4 |
6 | PROPHYLACTIC PLATELET TRANSFUSION | Author keyword | 6 | 100% | 0% | 4 |
7 | LYMPHOCYTOTOXICITY TEST | Author keyword | 4 | 75% | 0% | 3 |
8 | CORRECTED COUNT INCREMENT | Author keyword | 4 | 41% | 1% | 7 |
9 | PLATELET ALLOIMMUNIZATION | Author keyword | 3 | 57% | 0% | 4 |
10 | PROPHYLACTIC TRANSFUSION | Author keyword | 3 | 60% | 0% | 3 |
Web of Science journal categories |
Author Key Words |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | ALLOIMMUNIZED PATIENTS | 41 | 90% | 2% | 18 |
2 | THROMBOCYTOPENIC PATIENTS | 37 | 52% | 6% | 51 |
3 | PROGENITOR CELL TRANSPLANT | 26 | 87% | 2% | 13 |
4 | ALLOIMMUNIZED THROMBOCYTOPENIC PATIENTS | 24 | 68% | 2% | 21 |
5 | 20 000 MU L TRIGGER | 21 | 90% | 1% | 9 |
6 | 10 000 MU L | 18 | 83% | 1% | 10 |
7 | D GAMMA GLOBULIN | 17 | 100% | 1% | 8 |
8 | INCOMPATIBLE PLASMA | 17 | 75% | 1% | 12 |
9 | 20 000 MU L | 15 | 68% | 2% | 13 |
10 | HLA IMMUNIZED PATIENTS | 15 | 88% | 1% | 7 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
Utility of cross-matched platelet transfusions in patients with hypoproliferative thrombocytopenia: a systematic review | 2014 | 3 | 38 | 97% |
Platelet transfusion refractoriness | 2008 | 57 | 100 | 57% |
HLA alloimmunization against platelet transfusions: pathophysiology, significance, prevention and management | 2012 | 20 | 45 | 76% |
Relationship between platelet count and bleeding risk in thrombocytopenic patients | 2004 | 104 | 30 | 70% |
Do basic laboratory tests or clinical observations predict bleeding in thrombocytopenic oncology patients? | 2002 | 52 | 19 | 95% |
Transfusion Medicine 2 - Platelet transfusions | 2007 | 90 | 124 | 42% |
ABO-identical versus nonidentical platelet transfusion: a systematic review | 2009 | 18 | 29 | 93% |
Efficacy of HLA-matched platelet transfusions for patients with hypoproliferative thrombocytopenia: a systematic review | 2013 | 7 | 37 | 84% |
Platelet transfusion for patients with cancer: Clinical practice guidelines of the American Society of Clinical Oncology | 2001 | 236 | 96 | 35% |
Platelet transfusion: a systematic review of the clinical evidence | 2015 | 3 | 56 | 29% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | NHSBT MRC CLIN STUDIES UNIT | 1 | 100% | 0.2% | 2 |
2 | LONDON SE ZONE | 1 | 40% | 0.2% | 2 |
3 | ABT HAMATOL INNERE MED | 1 | 50% | 0.1% | 1 |
4 | BLOOD BANK SW | 1 | 50% | 0.1% | 1 |
5 | GI GU | 1 | 50% | 0.1% | 1 |
6 | IMMUNOHEMATOL BLOOD TRANSFUS ROMA OVEST | 1 | 50% | 0.1% | 1 |
7 | SLUZBA SPECIALNO DIAGNOST | 1 | 50% | 0.1% | 1 |
8 | TRANSFUS TRANSPLANT IMMUNOL | 1 | 50% | 0.1% | 1 |
9 | TRANSFUSIONSMED HAMOSTASEOL | 1 | 50% | 0.1% | 1 |
10 | TRANSLAT TRANSPLANT | 1 | 50% | 0.1% | 1 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000270385 | PLATELET STORAGE//PLATELETPHERESIS//PLATELET CONCENTRATES |
2 | 0.0000182790 | NEONATAL ALLOIMMUNE THROMBOCYTOPENIA//ALLOIMMUNE THROMBOCYTOPENIA//HUMAN PLATELET ANTIGENS |
3 | 0.0000154081 | ALLOIMMUNIZATION//TRANSFUS CELLULAR THER IES//DELAYED HEMOLYTIC TRANSFUSION REACTION |
4 | 0.0000123102 | GRANULOCYTE TRANSFUSION//GRANULOCYTE TRANSFUSIONS//GRANULOCYTE CONCENTRATES |
5 | 0.0000121823 | PASSENGER LYMPHOCYTE SYNDROME//ABO INCOMPATIBLE BMT//ABO MISMATCH |
6 | 0.0000082808 | IMMUNE THROMBOCYTOPENIA//IDIOPATHIC THROMBOCYTOPENIC PURPURA//ITP |
7 | 0.0000070356 | AMOTOSALEN//PATHOGEN INACTIVATION//SOLVENT DETERGENT |
8 | 0.0000066544 | TA GVHD//TRANSFUSION ASSOCIATED GRAFT VERSUS HOST DISEASE//POST TRANSFUSION GRAFT VERSUS HOST DISEASE |
9 | 0.0000065025 | SOLUBLE HLA//SOLUBLE HLA I//SOLUBLE HLA DR |
10 | 0.0000060707 | TRALI//TRANSFUSION RELATED ACUTE LUNG INJURY//HUMAN NEUTROPHIL ANTIGENS |